Peritoneal mesothelioma metastasis refers to the spread of peritoneal mesothelioma cancer cells from the primary site to distant areas in the body. Peritoneal mesothelioma is a rare and aggressive form of cancer that affects the peritoneum, which is the thin tissue lining the abdomen.
When peritoneal mesothelioma metastasizes, cancer cells can invade nearby organs within the abdominal cavity, such as the liver, spleen, intestines, and diaphragm. Additionally, cancer cells can also spread to distant sites through the lymphatic system or bloodstream, leading to metastasis in other areas of the body, such as the lungs, lymph nodes, or distant organs like the brain.
The metastasis of peritoneal mesothelioma can cause further complications and affect treatment options. It may require a multidisciplinary approach involving surgery, chemotherapy, radiation therapy, and targeted therapies to manage the spread of cancer cells. However, it is important to note that the prognosis for peritoneal mesothelioma is typically poor, and the treatment options may vary depending on the individual’s overall health, the extent of metastasis, and other factors.